Skip to content
Category

Lung cancer

page 1
lung cancer
cancer in the lung
carcinoid tumor
A carcinoid (also carcinoid tumor) is a slow-growing type of neuroendocrine tumor originating in the cells of the neuroendocrine system. In some cases, metastasis may occur. Carcinoid tumors of the midgut (jejunum, ileum, appendix, and cecum) are associated with carcinoid syndrome.
small cell carcinoma
type of carcinoma that commonly arises within lung and sometime other body sites
Pancoast tumor
tumor of the pulmonary apex
osimertinib
Osimertinib, sold under the brand name Tagrisso, is a medication used to treat non-small-cell lung carcinomas with specific mutations. It is a third-generation epidermal growth factor receptor tyrosine kinase inhibitor.
cutaneous squamous-cell carcinoma
skin carcinoma that has material basis in squamous cells
pneumonectomy
A pneumonectomy (or pneumectomy) is a surgical procedure to remove a lung. It was first successfully performed in 1933 by Dr. Evarts Graham. This is not to be confused with a lobectomy or segmentectomy, which only removes one part of the lung.
non-small-cell lung carcinoma
any type of epithelial lung cancer other than small-cell lung carcinoma
adenocarcinoma of the lung
non-small cell lung carcinoma that derives from epithelial cells of glandular origin
in situ pulmonary adenocarcinoma
lung cancer that derives from the distal bronchioles or alveoli that initially exhibit a specific non-invasive growth pattern
solitary pulmonary nodule
human disease
large-cell lung carcinoma
Disease
British Doctors Study
study (1951 to 2001) into smoking and lung cancer
squamous cell carcinoma of the lung
lung cancer
lurbinectedin
Lurbinectedin, sold under the brand name Zepzelca, is a medication used for the treatment of small cell lung cancer.
EGFR T790M
T790M, also known as Thr790Met, is a gatekeeper mutation of the epidermal growth factor receptor (EGFR). The mutation substitutes a threonine (T) with a methionine (M) at position 790 of exon 20, affecting the ATP binding pocket of the EGFR kinase domain. Threonine is a small polar amino acid; methionine is a larger nonpolar amino acid. Rather than directly blocking inhibitor binding to the active site, T790M increases the affinity for ATP so that the inhibitors are outcompeted; irreversible covalent inhibitors such as osimertinib can overcome this resistance.
Lung cancer staging
assessment of the extent to which a lung cancer has spread
pleuropulmonary blastoma
pulmonary blastoma that derives from the lung or pleural cavity
Lobectomy
surgical removal of a lobe of a lung
lung wedge resection
surgical operation